Evidence map›Paper›PMID 22081429›Full record

ReviewCurrent hypertension reports2012

An emerging role of degrading proteinases in hypertension and the metabolic syndrome: autodigestion and receptor cleavage.

Geert W Schmid-Schönbein

Open access · greenAbstract readReview
In one paragraph

Review in Current hypertension reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Distinct temporal phases of microvascular rarefaction in skeletal muscle of obese Zucker rats.American journal of physiology. Heart and circulatory physiology · 2014
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Geert W Schmid-SchönbeinDepartment of Bioengineering, Institute of Engineering in Medicine, University of California San Diego, La Jolla, CA 92093-0412, USA. gwss@ucsd.edu
University of California, San Diego · US

Funding

STRUCTURE/FUNCTION OF THE MICROCIRCULATIOMR01HL010881 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHMID-SCHOENBEIN, GEERT W. · 1985 to 2011
$3.1M
NHLBI NIH HHS HL 10881NHLBI NIH HHS R01 HL010881
6 · The paper itself

Abstract

One of the major challenges for hypertension research is to identify the mechanisms that cause the comorbidities encountered in many hypertensive patients, as seen in the metabolic syndrome. An emerging body of evidence suggests that human and experimental hypertensives may exhibit uncontrolled activity of proteinases, including the family of matrix metalloproteinases, recognized for their ability to restructure the extracellular matrix proteins and to play a role in hypertrophy. We propose a new hypothesis that provides a molecular framework for the comorbidities of hypertension, diabetes, capillary rarefaction, immune suppression, and other cell and organ dysfunctions due to early and uncontrolled extracellular receptor cleavage by active proteinases. The proteinase and signaling activity in hypertensives requires further detailed analysis of the proteinase expression, the mechanisms causing proenzyme activation, and identification of the proteinase substrate. This work may open the opportunity for reassessment of old interventions and development of new interventions to manage hypertension and its comorbidities.

Indexed as

ComorbidityExtracellular Matrix ProteinsHumansHypertensionHypertrophyImmune ToleranceMatrix MetalloproteinasesMetabolic SyndromeMicrocirculationModels, BiologicalReceptors, Cell SurfaceRenin-Angiotensin SystemSignal TransductionVasoconstrictionExtracellular Matrix ProteinsMatrix MetalloproteinasesReceptors, Cell Surface

Identifiers

PMID22081429
PMCPMC3253250
OpenAlexW2003042309

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.